CLINICAL_TRIALS trial_result · 2014-06-23

Clinical Trial Update: Stage I/II Nasal NK Cell Lymphoma [Phase 1, Phase 2]

A Phase 1/Phase 2 trial assessing Stage I/II nasal NK/T-cell lymphoma (nasal type) was terminated; results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-06-23